Europe — EMA
Noradrenaline (Norepinephrine) Wockhardt Uk (Noradrenaline Tartrate)
GNH USA supplies Noradrenaline (Norepinephrine), a vasopressor for hypotension, shock and cardiac arrest. Request a quote for supply to hospitals and clinics.
Request sourcing
What is Noradrenaline Tartrate?
Norepinephrine, the active ingredient in Noradrenaline (Norepinephrine) Wockhardt Uk, is an adrenergic agonist presented as an injection for intravenous use. It is employed in acute care to raise blood pressure and improve cardiac output in patients with hypotension, various forms of shock, and during cardiac arrest.
GNH USA supplies Noradrenaline (Norepinephrine) Wockhardt Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, with manufacturing sourced from the European Union and meeting stringent quality standards for vasopressor therapy across diverse clinical settings.
What is Noradrenaline Tartrate used for?
Noradrenaline (norepinephrine) acts on the adrenergic system to restore vascular tone and cardiac output in critical care.
- Hypotension: increases systemic vascular resistance to raise arterial pressure in patients with low blood pressure. - Shock: improves perfusion pressure and organ blood flow in septic, cardiogenic or hypovolemic shock states. - Cardiac arrest: supports coronary and cerebral circulation during resuscitation efforts.
What are the side effects of Noradrenaline Tartrate?
Norepinephrine may produce a range of adverse reactions, which are classified by frequency and severity.
Common Side Effects: - Tachycardia: rapid heart rate due to β1 stimulation. - Hypertension: excessive rise in blood pressure from α1 vasoconstriction. - Arrhythmia: irregular cardiac rhythm, especially in susceptible patients. - Headache: vascular headache related to pressure changes. - Anxiety or restlessness: central nervous system stimulation. - Peripheral ischemia: reduced blood flow to extremities causing coldness or pain.
Serious or Rare Side Effects: - Myocardial ischemia: chest pain or infarction from increased cardiac workload. - Severe hypertension: dangerous elevation of blood pressure requiring immediate intervention. - Tissue necrosis at infusion site: extravasation leading to local tissue damage. - Pulmonary edema: fluid accumulation in lungs due to cardiac overload. - Cardiac arrest: paradoxical cessation of heart activity in rare cases.
What precautions apply to Noradrenaline Tartrate?
When using norepinephrine, clinicians should observe specific safety measures to minimize complications.
- Monitor blood pressure: adjust infusion rate to avoid excessive hypertension. - Cardiac monitoring: continuous ECG to detect arrhythmias. - Use cautiously in coronary artery disease: risk of myocardial ischemia. - Avoid rapid bolus administration: give as controlled infusion. - Adjust dose in hypovolemia: ensure adequate fluid resuscitation before vasopressor. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Noradrenaline Tartrate interact with?
Norepinephrine can interact with other medicines, altering its pressor effect or safety profile.
Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Tricyclic antidepressants: additive pressor response increasing blood pressure. - Beta‑blockers: can blunt expected tachycardia and mask hypotension.
Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive effect. - ACE inhibitors: can augment blood pressure variability.



